Business · 20/10/2023Updated: 10/17/2026 · 1 min read
FDA Releases Revised Guidance for COVID-19 Vaccine Development and Licensure
Summary
The US Food and Drug Administration (FDA) has updated its guidance for the development and licensure of COVID-19 vaccines, providing key considerations for regulatory requirements and post-licensure safety evaluation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →